These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1982264

  • 1. Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Eur J Pharmacol; 1990 Nov 27; 191(2):213-6. PubMed ID: 1982264
    [Abstract] [Full Text] [Related]

  • 2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 27; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 3. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Brain Res; 1990 Oct 08; 529(1-2):85-90. PubMed ID: 1980848
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 5. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov 28; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 6. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 7. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR, McKenna DJ, Peroutka SJ.
    Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011
    [Abstract] [Full Text] [Related]

  • 8. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 25; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 9. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM, Cunningham KA.
    Brain Res Bull; 1992 Jan 25; 28(1):115-9. PubMed ID: 1347247
    [Abstract] [Full Text] [Related]

  • 10. Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
    Finnegan KT, Calder L, Clikeman J, Wei S, Karler R.
    Brain Res; 1993 Feb 12; 603(1):134-8. PubMed ID: 8095837
    [Abstract] [Full Text] [Related]

  • 11. The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Finnegan KT, Skratt JJ, Irwin I, Langston JW.
    Neurosci Lett; 1989 Nov 06; 105(3):300-6. PubMed ID: 2574428
    [Abstract] [Full Text] [Related]

  • 12. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").
    Colado MI, Granados R, O'Shea E, Esteban B, Green AR.
    Pharmacol Toxicol; 1999 Jun 06; 84(6):261-6. PubMed ID: 10401727
    [Abstract] [Full Text] [Related]

  • 13. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K, Goromaru T.
    Fundam Clin Pharmacol; 1990 Jun 06; 4(6):635-41. PubMed ID: 1710592
    [Abstract] [Full Text] [Related]

  • 14. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K, Maeda H, Goromaru T.
    Brain Res; 1992 Sep 11; 590(1-2):341-4. PubMed ID: 1384935
    [Abstract] [Full Text] [Related]

  • 15. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system.
    Pan HS, Wang RY.
    Brain Res; 1991 Mar 08; 543(1):56-60. PubMed ID: 1675924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ.
    J Pharmacol Exp Ther; 1987 Jan 08; 240(1):1-7. PubMed ID: 2433425
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
    Hashimoto K, Maeda H, Goromaru T.
    Eur J Pharmacol; 1992 Sep 01; 228(2-3):171-4. PubMed ID: 1280228
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 01; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.